Review of Genetic Testing Companies During 2024

By Robert Michel | From the Volume XXXII, No. 1 – January 6, 2025 Issue

CEO SUMMARY: Investors in genetic testing companies are taking it on the chin these days. During 2024, a number of the nation’s largest firms providing genetic test services reported significant losses. Other genetic testing companies are dealing with class action lawsuits claiming that…

Read More

---

January 6, 2025, Intelligence: Late-Breaking Lab News

By Robert Michel | From the Volume XXXII, No. 1 – January 6, 2025 Issue

In response to the 2021 federal law requiring all medical test results to be released to a patient’s electronic medical record upon availability, a team of researchers at Michigan Medicine recently conducted a study to learn whether patients could understand the standard pathology …

Read More

---

November 25, 2024, Intelligence: Late-Breaking Lab News

By Robert Michel | From the Volume XXXI, No. 16 – November 25, 2024 Issue

Disruption is happening in the consumer genetic testing marketplace. In recent weeks, news outlets in the United Kingdom reported that Atlas Biomed, a consumer genetic testing company founded in 2016, had simply “disappeared.” Malwarebytes said Atlas Biomed’s “London offices …

Read More

---

Getting Test Claims Paid & Class Action Lawsuits

By R. Lewis Dark | From the Volume XXXI No. 15 – November 4, 2024 Issue

When you crack open this issue of The Dark Repor…

Read More

---

Insights from Q3 2024 Earnings Calls Point to a More Robust Lab Market

By Robert Michel | From the Volume XXXI No. 15 – November 4, 2024 Issue

FOR THE THIRD QUARTER OF 2024 (Q3 2024), both of the nation’s largest publicly traded laboratories—Labcorp…

Read More

---

November 4, 2024, Intelligence: Late-Breaking Lab News

By Robert Michel | From the Volume XXXI No. 15 – November 4, 2024 Issue

Artificial intelligence (AI) is coming to the federal Food and Drug Administration (FDA) and the Veterans Administration (VA). Last week, on Oct. 30, the two agencies issued an announcement that they would partner “to launch an interagency testing ground forchealth…

Read More

---

Once Again, Congress Acts to Defer Medicare Lab Fee Cuts

By Robert Michel | From the Volume XXXI, No. 14 – October 14, 2024 Issue

LAST MONTH, CONGRESS ONCE AGAIN DEFERRED MEDICARE REIMBURSEMENT CUTS OF UP TO 15% f…

Read More

---

Allina Doctors Express Concerns after Quest Acquires Lab Outreach

By Robert Michel | From the Volume XXXI, No. 14 – October 14, 2024 Issue

IN RECENT YEARS, QUEST DIAGNOSTICS AND LABCORP, the two behemoths of the U.S. clinical laboratory market, have been aggressively acquiring lab businesses from health systems across the country. They say that patients and providers will benefit from lower costs and be…

Read More

---

Hospital Lab Outreach: Still a Valuable Asset!

By Robert Michel | From the Volume XXXI, No. 13 – September 23, 2024 Issue

CEO SUMMARY: Hospital lab administrators everywhere are watching press releases announcing the latest agreement of a major health system selling its laboratory outreach business to one of the billion-dollar lab corporations. The pace of these sales is accelerating. These deals confirm the…

Read More

---

Watch Out Pathologists! They’re Coming for Histology!

By R. Lewis Dark | From the Volume XXXI, No. 11 – August 12, 2024 Issue

For any lab that depends on revenue from its histology labo…

Read More

---